论文部分内容阅读
目的分析肝炎肝硬化患者肝功能检验结果及在临床治疗上的意义。方法分析我院2013年1~12月收治的112例肝炎肝硬化患者,检测112例患者的血清胆固醇(CHO)、白蛋白(ALB)、血清胆碱酯酶(CHE)、总胆汁酸(TBA)水平。同时随机选取本院同期收治的84例正常体检人员做为对照组进行肝功能检测;比较Child三个分级的CHO、ALB、CHE、TBA水平。结果 (1)对照组与治疗组比较,CHO、ALB、CHE、TBA水平有显著性差异(P<0.05;0.005)。(2)Child B组、Child C组与Child A组比较,CHO、ALB、CHE、TBA水平有显著性差异(P<0.05;0.01)。结论对肝炎肝硬化患者进行肝功能检测,可以签别诊断肝炎肝硬化患者,同时对肝炎肝硬化患者的肝脏受损程度进行区分。
Objective To analyze the results of liver function tests in patients with liver cirrhosis and its clinical significance. Methods One hundred and twelve patients with hepatitis cirrhosis who were admitted to our hospital from January to December in 2013 were enrolled in this study. Serum cholesterol (CHO), albumin (ALB), serum cholinesterase (CHE), total bile acid (TBA) )Level. At the same time, we randomly selected 84 normal subjects who were treated in our hospital as the control group to test the liver function. The level of CHO, ALB, CHE and TBA in Child were compared. Results (1) The levels of CHO, ALB, CHE and TBA in the control group and the treatment group were significantly different (P <0.05; 0.005). (2) The levels of CHO, ALB, CHE and TBA in Child B group and Child C group were significantly different from those in Child A group (P <0.05; 0.01). Conclusions Hepatic function test in patients with liver cirrhosis can sign the diagnosis of liver cirrhosis patients, at the same time distinguish the degree of liver damage in patients with liver cirrhosis.